Pulmonx (LUNG) Assets Average (2020 - 2025)

Pulmonx (LUNG) has 6 years of Assets Average data on file, last reported at $133.8 million in Q4 2025.

• Quarterly Assets Average fell 18.98% year-over-year to $133.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $133.8 million (down 18.98% YoY) and the FY2025 annual result came in at $146.1 million, down 14.24% from the prior year.
• Assets Average declined to $133.8 million in Q4 2025 per LUNG's latest filing, from $142.7 million in the prior quarter.
• Across five years, Assets Average topped out at $259.5 million in Q1 2021 and bottomed at $133.8 million in Q4 2025.
• The 5-year median for Assets Average is $193.1 million (2023), against an average of $193.8 million.
• The widest annual swing landed in 2021, when Assets Average soared 43.9%; it then fell 18.98% in 2025.
• Tracing LUNG's Assets Average over 5 years: stood at $241.0 million in 2021, then slipped by 17.87% to $197.9 million in 2022, then retreated by 8.36% to $181.4 million in 2023, then retreated by 8.97% to $165.1 million in 2024, then slipped by 18.98% to $133.8 million in 2025.
• Per Business Quant, the three latest LUNG Assets Average figures stand at $133.8 million (Q4 2025), $142.7 million (Q3 2025), and $149.0 million (Q2 2025).

Peer Comparison